What Molecular Cancer Therapeutics specifies
The figures below follow your selected manuscript type. Review proposed changes and verify the final manuscript against the official author guidance.
- First Disclosures 5 rules, including: word limit (5000 words), abstract word limit (250 words), reference limit (50 references), display item limit (6 items).
Read from Molecular Cancer Therapeutics's own author guidelines. Journals revise these - verify with the journal before you submit.
Preparing a submission for Molecular Cancer Therapeutics
Scraiber has 15 requirements on file for Molecular Cancer Therapeutics, covering areas such as length, references, structure and submission policies. The journal’s official guidance remains the reference for your submission.
Select Molecular Cancer Therapeutics and your manuscript type, then upload your draft to preview proposed text changes. Review the suggestions before applying them.
Retargeting a manuscript to Molecular Cancer Therapeutics may require changes to length, structure, references and declarations. Scraiber suggests revisions to your existing draft; authors must check the scientific meaning and supply any missing factual declarations.
Manuscript types at Molecular Cancer Therapeutics
Recorded manuscript types for Molecular Cancer Therapeutics: First Disclosures, Letters to the Editor, Research Articles, Reviews. Select the type you intend to submit so the preview uses the corresponding requirements.
Changes to review in your manuscript
Scraiber proposes text revisions informed by Molecular Cancer Therapeutics’s recorded requirements. Check each change for scientific meaning, references and missing declarations. Authors remain responsible for the final manuscript.
Frequently asked questions
- What is the word limit for Molecular Cancer Therapeutics?
- Select your manuscript type to see the recorded length figures for Molecular Cancer Therapeutics. Check the official guidance for exclusions, recommendations and any updated limits.
- How do I check my manuscript against the Molecular Cancer Therapeutics guidelines?
- Choose your manuscript type and follow the preview button to upload a .docx for Molecular Cancer Therapeutics. Review the proposed changes and the price before deciding whether to unlock the full rewrite.
- What are the submission requirements for Molecular Cancer Therapeutics?
- Scraiber has 15 requirements on file for Molecular Cancer Therapeutics. Choose your manuscript type to see recorded limits and consult the linked official guidance for the current submission requirements.
- Which citation style does Molecular Cancer Therapeutics use?
- Consult Molecular Cancer Therapeutics’s official guidance for its citation style. Scraiber can suggest revisions using the recorded requirements; check citations and the bibliography before submission.
- Can I automatically format my paper for Molecular Cancer Therapeutics?
- Upload your draft and select Molecular Cancer Therapeutics and your manuscript type. Scraiber proposes text changes for review. Check the final manuscript against the official guidance; the preview does not guarantee complete compliance or acceptance.
- How do I reformat a paper rejected by another journal for Molecular Cancer Therapeutics?
- Select Molecular Cancer Therapeutics and the manuscript type, then upload your existing draft. Review the proposed revisions and check references, declarations and scientific meaning before submission.
- How long does it take to prepare a manuscript for Molecular Cancer Therapeutics?
- Preparation time depends on your draft, the journal’s requirements and the author review needed. A preview lets you inspect proposed changes before deciding to continue.
- Does Molecular Cancer Therapeutics have different requirements per manuscript type?
- Yes. Requirements for Molecular Cancer Therapeutics vary by manuscript type. Your selection determines which recorded requirements inform the proposed revisions.
- Do I have to redo my references for Molecular Cancer Therapeutics?
- Review your citations and bibliography against Molecular Cancer Therapeutics’s current guidance. Suggested text changes do not replace checking the accuracy, completeness and style of your references.
Official author guidelines: aacrjournals.org
